Compassionate use programme for treatment of Crohn's disease with QBECO.

Trial Profile

Compassionate use programme for treatment of Crohn's disease with QBECO.

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 28 Jul 2015

At a glance

  • Drugs QBECO (Primary)
  • Indications Crohn's disease
  • Focus Adverse reactions; Expanded access; Therapeutic Use
  • Sponsors Qu Biologics
  • Most Recent Events

    • 28 Jul 2015 Results published in Qu Biologics media release.
    • 03 Nov 2014 New trial record
    • 29 Oct 2014 Results published in a Qu Biologics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top